Capital Fund Management S.A. Zai Lab LTD Transaction History

Capital Fund Management S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$25.3 - $39.67 $1.64 Million - $2.57 Million	64,689 New	64,689 $1.79 Million
Q4 2022 Feb 13, 2023	SELL	$22.28 - $38.71 $107,545 - $186,853	-4,827 Reduced 5.56%	81,927 $2.52 Million
Q3 2022 Nov 14, 2022	SELL	$34.2 - $51.69 $229,071 - $346,219	-6,698 Reduced 7.17%	86,754 $2.97 Billion
Q2 2022 Aug 12, 2022	BUY	$23.14 - $49.68 $1.79 Million - $3.85 Million	77,445 Added 483.82%	93,452 $3.24 Million
Q1 2022 May 12, 2022	SELL	$27.77 - $64.4 $1.18 Million - $2.73 Million	-42,367 Reduced 72.58%	16,007 $703,000
Q4 2021 Feb 10, 2022	BUY	$54.9 - $105.21 $3.2 Million - $6.14 Million	58,374 New	58,374 $3.67 Million

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.43B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.